ICAM1 and cervical cancer: We next quantified ICAM1 overexpression in human cervical cancer cells (SiHa and CaSki) by flow cytometry and immunofluorescence staining, which are 80- and 106-fold higher than those of non-neoplastic HcerEpic and 293T cells, respectively (Fig. 1f, g).